Products for Research Use Only
RegisterLogin

Urelumab

CAT: 0804-HY-P99055-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99055-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab. Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL).
CAS Number
934823-49-1
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/urelumab.html
Purity
99.33
Solubility
H2O
Smiles
[Urelumab]
Molecular Weight
(145.82 kDa)
References & Citations
[1]John Timmerman, et al. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. Am J Hematol. 2020 May;95 (5) :510-520.|[2]Cheng LS, et al. A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity. J Transl Med. 2022 Sep 8;20 (1) :415.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5819193Urelumab
GTR18320582-01Urelumab Antibody
HC336026-01Research Grade Urelumab
GTR18872258Urelumab ELISA Kit
KBI1711KRIBIOLISA™ Urelumab ELISA
E55B0390Urelumab (Reference antibody)
A138607Urelumab Biosimilar (Monoclonal, IgG4)
ABS-307-1mgUrelumab Biosimilar, Research Grade
ICH5015-200mgUrelumab Biosimilar - Research Grade
GTR18780853-01(Urelumab) Biosimilar Reference Antibody

Popular Products